EndoCeutics Inc-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:EndoCeutics Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8011830
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月13日
◆ページ数:21
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:カナダ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
EndoCeutics Inc (EndoCeutics) is a pharmaceutical company that develops hormone sensitive cancer prevention therapies for women’s health. The company’s pipeline product portfolio includes drugs for various indications such as endometriosis; male hypogonadism and antiandrogens, among others. It develops non estrogen-based therapies for vulvovaginal atrophy, sexual dysfunction and the other symptoms of menopause that includes osteoporosis, hot flushes, muscle loss and type II diabetes. EndoCeutics’ hormonal therapies used for the treatment of uterine, breast, and prostate cancer, and endometriosis are under development. It also offers analytical, bio-analytical and other research and development services. The company operates through its laboratory located in Quebec. EndoCeutics is headquartered in Quebec, Canada.

EndoCeutics Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
EndoCeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
EndoCeutics Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
EndoCeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
EndoCeutics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
EndoCeutics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
EndoCeutics Inc, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
Sermonix Pharma Raises USD4.2 Million in Seed Financing 10
Sermonix Pharma Raises USD4.2 Million in Seed Preferred Equity Bridge Financing 11
Partnerships 12
Veristat Extends Partnership with EndoCeutics 12
Licensing Agreements 13
AMAG Pharma and Endoceutics Pharma Enter into Licensing Agreement 13
EndoCeutics Inc – Key Competitors 15
EndoCeutics Inc – Key Employees 16
EndoCeutics Inc – Locations And Subsidiaries 17
Head Office 17
Other Locations & Subsidiaries 17
Recent Developments 18
Product News 18
07/24/2017: AMAG Pharmaceuticals Launches Intrarosa (prasterone) in the U.S. – a Novel Product to Treat Moderate to Severe Dyspareunia Due to Menopause 18
Product Approvals 19
Nov 17, 2016: FDA approves Intrarosa for postmenopausal women experiencing pain during sex 19
Clinical Trials 20
Jan 05, 2016: DHEA Improves Vaginal Discomfort After Menopause 20
Appendix 21
Methodology 21
About GlobalData 21
Contact Us 21
Disclaimer 21

List of Tables
EndoCeutics Inc, Pharmaceuticals & Healthcare, Key Facts 2
EndoCeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
EndoCeutics Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
EndoCeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
EndoCeutics Inc, Deals By Therapy Area, 2011 to YTD 2017 8
EndoCeutics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Sermonix Pharma Raises USD4.2 Million in Seed Financing 10
Sermonix Pharma Raises USD4.2 Million in Seed Preferred Equity Bridge Financing 11
Veristat Extends Partnership with EndoCeutics 12
AMAG Pharma and Endoceutics Pharma Enter into Licensing Agreement 13
EndoCeutics Inc, Key Competitors 15
EndoCeutics Inc, Key Employees 16
EndoCeutics Inc, Other Locations 17
EndoCeutics Inc, Subsidiaries 17

★海外企業調査レポート[EndoCeutics Inc-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Samsung Biologics Co Ltd (207940):製薬・医療:M&Aディール及び事業提携情報
    Summary Samsung Biologics Co Ltd (Samsung Biologics) is a biologics development and manufacturing company. The company’s business activities include process development, contract manufacturing, aseptic fill and finish and project management. Samsung Biologics cell culture development process include …
  • Northland Power Inc (NPI):電力:M&Aディール及び事業提携情報
    Summary Northland Power Inc. (Northland Power) is an independent power producer that develops, finances, builds, owns, and operates clean and green power projects in Canada and internationally. The company generates energy from natural gas, biomass, landfill gas, wind and solar sources. In thermal g …
  • MLM Biologics Inc:企業の製品パイプライン分析2018
    Summary MLM Biologics Inc (MLM Biologics) is a medical device company that provides optimum wound care management for patients and doctors. The company’s product includes bio-ConneKt Wound Matrix, a collagen-based wound dressing for chronic vascular ulcers, draining wounds, partial and full thicknes …
  • Otsuka Corp (4768):企業の財務・戦略的SWOT分析
    Otsuka Corp (4768) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Turner Price Ltd:企業の戦略・SWOT・財務情報
    Turner Price Ltd - Strategy, SWOT and Corporate Finance Report Summary Turner Price Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • OPTIMA packaging group GmbH:戦略・SWOT・企業財務分析
    OPTIMA packaging group GmbH - Strategy, SWOT and Corporate Finance Report Summary OPTIMA packaging group GmbH - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • British Columbia Cancer Agency-医療機器分野:企業M&A・提携分析
    Summary British Columbia Cancer Agency (BC Cancer Agency), a subsidiary of Provincial Health Services Authority is a healthcare service center that provides comprehensive cancer control program. The center offers services such as patient assessment, diagnostic and therapy planning, radiation therapy …
  • PricewaterhouseCoopers LLP (UK):企業の戦略的SWOT分析
    PricewaterhouseCoopers LLP (UK) - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pro …
  • LumiraDx Ltd (LMDX):企業の財務・戦略的SWOT分析
    LumiraDx Ltd (LMDX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Mallinckrodt plc:企業の戦略・SWOT・財務分析
    Mallinckrodt plc - Strategy, SWOT and Corporate Finance Report Summary Mallinckrodt plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Selective Insurance Group, Inc. (SIGI):企業の財務・戦略的SWOT分析
    Selective Insurance Group, Inc. (SIGI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths a …
  • Fidelity National Financial Inc:企業の戦略・SWOT・財務情報
    Fidelity National Financial Inc - Strategy, SWOT and Corporate Finance Report Summary Fidelity National Financial Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Bank Zachodni WBK SA:戦略・SWOT・企業財務分析
    Bank Zachodni WBK SA - Strategy, SWOT and Corporate Finance Report Summary Bank Zachodni WBK SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • CF Industries Holdings Inc (CF):企業の財務・戦略的SWOT分析
    CF Industries Holdings Inc (CF) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • Aptiv Plc
    Aptiv Plc - Strategy, SWOT and Corporate Finance Report Summary Aptiv Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions …
  • GW Pharmaceuticals Plc (GWP)-製薬・医療分野:企業M&A・提携分析
    Summary GW Pharmaceuticals plc (GW Pharmaceuticals) is a biopharmaceutical company which discovers, develops and commercializes innovative therapeutics from its proprietary cannabinoid product platform. The company’s commercialized product, Sativex is a plant-derived cannabinoid prescription drug, f …
  • Epax Norway AS:戦略・SWOT・企業財務分析
    Epax Norway AS - Strategy, SWOT and Corporate Finance Report Summary Epax Norway AS - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • International Finance Corporation:企業の戦略的SWOT分析
    International Finance Corporation - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major p …
  • Piramal Glass Ltd:企業の戦略・SWOT・財務情報
    Piramal Glass Ltd - Strategy, SWOT and Corporate Finance Report Summary Piramal Glass Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • CryoPort Inc (CYRX):製薬・医療:M&Aディール及び事業提携情報
    Summary Cryoport, Inc. (Cryoport) is a provider of cold chain logistics solutions for temperature-sensitive biological materials to the life science industries. It offers liquid nitrogen dry vapor shippers with advanced logistics management platform called Cryoportal, which provides credentials rela …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆